Mesothelioma Survival Rate
Mesothelioma survival rate helps doctors provide a prognosis and allows patients to make preparations based on their diagnosis. It's an average or percentage based on past cases of the cancer. The survival rates for mesothelioma are improving due to new treatments.
What Is a Survival Rate?
Survival rate is the percentage of patients who reach a specific survival benchmark with a deadly disease. It’s usually measured in increments of every six months or one year. The measurement begins either once the patient is diagnosed or after a specific treatment. It ends when the patient passes away. Doctors then combine multiple cases to form a survival rate.
The survival rate is based on past cases. Therefore, it’s not a prediction of survival for a current or future case. It’s rather a benchmark for doctors and patients.
Survival rate can be broken down into age groups, gender, type, treatment and more. This gives a more accurate prediction for each individual case.
What Is the Survival Rate for Mesothelioma?
The rates decrease for longer survival. However, treatment can help improve the chances.
The rate increases dramatically after successful surgery. It improves incrementally for other therapies, such as chemotherapy, immunotherapy and tumor treating fields.
Underreported Factors Affecting Survival Rates
Current Survival Results
Survival rates don’t always reflect current data. Doctors examine the results of people treated in the past in order to provide this data. They only offer a glimpse into the past, not the future.
New Treatment Options
Survival rates do not account for new treatment options. Many of these treatments were not available at the time the data was collected. Mesothelioma treatment options have been developing quickly through clinical trials in the past decade. For instance, immunotherapy outperforms chemotherapy in survival by four months. The one-year and two-year rates are also better for immunotherapy.
General survival averages can be misleading because they include patients who didn’t receive treatment. They also include patients treated by general oncologists rather than mesothelioma specialists. Lastly, they include cases affected by patient-specific factors, such as age, gender and poor health.
Patients and families should remember that all statistics have a degree of error.
Location of Tumors
A study by the National Cancer Institute found that peritoneal mesothelioma has a better long-term survival average.
Some pleural mesothelioma cases may outlast peritoneal mesothelioma cases. While the location matters, it’s not the only factor in determining survival. The rates, or averages, do provide more hope to peritoneal cases.
Survival percentages change for each stage of mesothelioma. There is a strong correlation between mesothelioma stage and patient life span. Patients diagnosed at the early stages (with less metastasis) have significantly longer survival rates.
Mesothelioma is more often diagnosed in the later stages because of the lack of obvious symptoms of mesothelioma. Survival data in stages 3 and 4 are lower because the cancer is more advanced and more difficult to treat.
According to one study, the two-year survival rate for stage 1 is around 60% after surgery. For stage 4, the two-year survival rate after surgery is around 20%. Stages 2 and 3 are closer to 40%.
Cell Type and Histology
Mesothelioma can develop as one of three histological cell types or variations: epithelioid, biphasic or sarcomatoid. Cell type is an important factor in survival. Generally, epithelioid mesothelioma has the best survival rate because it reacts better to treatment. Sarcomatoid has the poorest rate due to spreading quickly.
Dr. David Sugarbaker completed a study in 1996 involving 120 mesothelioma patients, which illuminated how important cell type is to survival. It is important to keep in mind multimodal therapy is the most successful type of treatment for mesothelioma and other studies have varying results.
Survival Rate by Cell Type After Multimodal Therapy
Survival statistics for biphasic cell types aren’t consistent. The ratio of epithelioid cells to sarcomatoid cells affects survival. A higher percentage of epithelioid cells usually has a better outcome.
Each cell type is unique, which is why patients should find a mesothelioma specialist to treat them. Mesothelioma specialists can offer specific expertise to their patients.